StonvexLoading…
StonvexStonvexStonvexCore line items from MGTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $15.92M | $37.70M | $15.56M | $13.29M |
Operating Income | $-116.36M | $-72.76M | $-62.55M | $-58.27M |
Net Income | $-129.62M | $-79.56M | $-57.99M | $-54.75M |
EPS (Diluted) | $-2.87 | $-1.80 | $-1.54 | Not available |
Total Assets | $318.24M | $320.16M | $363.70M | $323.89M |
Total Liabilities | $200.50M | $134.76M | $125.14M | $133.09M |
Cash & Equivalents | $115.52M | $137.70M | $209.52M | $227.23M |
Free Cash Flow OCF − CapEx | $-118.06M | $-56.88M | $-84.89M | $11.06M |
Shares Outstanding | 48.48M | 44.55M | 44.19M | 36.79M |